SIBO and Acid Reflux: The Hidden Gut Connection Behind Your Symptoms

SIBO (small intestinal bacterial overgrowth) and acid reflux share a powerful bidirectional relationship. Bacteria that overgrow in the small intestine ferment food, producing excess gas that pushes up against the lower esophageal sphincter (LES) and forces it open — triggering reflux. At the same time, GERD and long-term PPI use can deplete the stomach acid that normally keeps bacterial populations in check, creating the very conditions that allow SIBO to develop or worsen.

What makes this connection especially important for LPR (silent reflux) sufferers is that SIBO is increasingly being linked not just to heartburn and regurgitation, but to the throat-based symptoms — chronic cough, throat clearing, globus sensation — that make LPR so difficult to diagnose and treat.

If your reflux symptoms haven’t responded well to PPIs, SIBO may be a significant part of the picture that’s being overlooked.

Key Takeaways

• SIBO causes bacterial fermentation that produces gas, raising intra-abdominal pressure and forcing the LES open — a direct mechanical trigger for acid reflux.
• A 2025 study of 394 patients found that GERD was significantly more common in SIBO-positive patients (24.4%) vs SIBO-negative patients (13.2%), with GERD identified as an independent risk factor for SIBO.
• The association is strongest with methane-producing SIBO (SIBO-CH₄), which has a particularly strong link to GERD and constipation-related reflux.
• 60.6% of patients referred for anti-reflux surgery already had intestinal dysbiosis — many unaware of it.
• Long-term PPI use for reflux moderately increases SIBO risk by reducing the stomach acid that prevents bacterial overgrowth.
• SIBO is directly linked to worse LPR symptoms including throat clearing, cough, and globus pharyngeus — even when acid exposure time is similar to non-SIBO patients.
• Treating SIBO in reflux patients allowed 95% to reduce or stop PPIs entirely in a 2025 clinical study.
• A breath test is the standard, non-invasive way to screen for SIBO — and it’s something many reflux patients have never been offered.

What Is SIBO and Why Does It Matter for Reflux?

The small intestine is supposed to be a relatively quiet place — low in bacteria, focused on absorbing nutrients. The stomach produces hydrochloric acid partly to ensure that anything swallowed doesn’t set up camp too far down the digestive tract. But when that system breaks down — whether through reduced acid, poor gut motility, or structural issues — bacteria migrate into the small intestine and thrive on the food you eat before it’s properly digested.

That fermentation process is the key to understanding the SIBO-reflux link. When bacteria ferment carbohydrates in the small intestine, they produce hydrogen and methane gases. Those gases create pressure — upward pressure that the lower esophageal sphincter (LES) has to resist. For anyone with a weakened or struggling LES, that extra pressure is often the difference between keeping acid down and letting it reflux into the esophagus and throat. You can read more about how the lower esophageal sphincter works and why it fails in this article.

SIBO is not rare. It overlaps significantly with irritable bowel syndrome (IBS), and research now shows it appears in a large percentage of people who have been diagnosed with GERD or LPR — many of whom don’t realise it’s a factor.

The Research: How Strongly Is SIBO Linked to GERD and LPR?

The evidence connecting SIBO to reflux has become increasingly difficult to ignore, particularly over the last few years. Several high-quality studies have now established this relationship from multiple angles.

A large retrospective study published in the Journal of Inflammation Research in 2025 examined 394 patients who underwent both gastroscopy and hydrogen-methane breath testing. The results were striking. GERD was significantly more prevalent among SIBO-positive patients (24.4%) compared to those who tested negative for SIBO (13.2%). Logistic regression analysis identified GERD as an independent risk factor for developing SIBO — meaning the connection isn’t coincidental. The GERD-SIBO correlation was strongest in patients with methane-producing SIBO (SIBO-CH₄), which raises an interesting point about the role of constipation and slower gut transit in this cycle [Wang et al., Journal of Inflammation Research, 2025].

A separate study looking at patients being evaluated for anti-reflux surgery found that 60.6% already had intestinal dysbiosis — 39.4% had SIBO and 35.6% had intestinal methanogen overgrowth (IMO). These patients were far more likely to report bloating and belching, and critically, they were significantly more likely to have a positive reflux-symptom association on pH-impedance testing — meaning their symptoms were directly tied to reflux events [Haworth et al., Surgical Endoscopy, 2021].

The LPR-specific data is particularly relevant to many readers of this site. A 2023 study published in the Gastrointestinal Tract journal specifically explored the relationship between SIBO and LPR. Of 41 patients analysed, 46.3% tested positive for SIBO. Those with SIBO had significantly higher LPR symptom severity scores on the Reflux Symptom Index (RSI), particularly for throat clearing, cough, and globus sensation. Objectively, their acid exposure time wasn’t dramatically different — but their mucosal integrity in the proximal esophagus was measurably impaired, suggesting that SIBO is affecting the tissue itself, not just the amount of acid [Haworth et al., Gastrointestinal Tract, 2023].

If you’re dealing with silent reflux or LPR symptoms that haven’t improved despite medication, this research suggests SIBO deserves serious consideration as a contributing factor.

How SIBO Actually Causes Reflux: The Mechanisms

Understanding the mechanisms matters, because it explains why treating acid alone — which is what PPIs do — often doesn’t fully resolve symptoms when SIBO is involved.

Gas Pressure and the Lower Esophageal Sphincter

The most direct mechanism is mechanical. When bacteria in the small intestine ferment undigested carbohydrates, they produce hydrogen and methane gases. These gases build pressure in the gastrointestinal tract. That upward pressure weakens the LES — the valve between the stomach and the esophagus — and triggers what are called transient lower esophageal sphincter relaxations (TLESRs). TLESRs are the main mechanism behind most acid reflux episodes. So essentially, SIBO is driving the valve open at the wrong times.

The Belching-Aerosol Problem

This mechanism is especially relevant to LPR. When patients with SIBO belch, they don’t just release gas. They release an aerosol — a fine mist of gastric contents including stomach acid, pepsin, and bile — that can travel up the esophagus and reach the throat, sinuses, and in some cases even the airways. Pepsin is biologically active in mildly acidic environments and is highly irritating to the sensitive tissues of the throat and larynx. This explains why so many LPR patients have throat symptoms that don’t respond to PPIs: the problem isn’t just acid, it’s what’s coming up with the gas. You can read more about how LPR symptoms like post-nasal drip develop.

Delayed Gastric Emptying

SIBO can impair gut motility — the coordinated muscular contractions that move food through the digestive tract. When gastric emptying slows down, food and acid remain in the stomach longer, increasing the chance that contents will reflux upward. Constipation, which is strongly associated with methane-producing SIBO (IMO), also plays a role here: evidence shows that colonic distension increases the frequency of TLESRs, creating yet another pathway from bacterial overgrowth to reflux.

Mucosal Barrier Damage

Perhaps the most insidious mechanism is what SIBO does to the esophageal lining over time. The Haworth et al. 2023 study mentioned above found that SIBO patients had significantly reduced mean nocturnal baseline impedance (MNBI) in the proximal esophagus — a measure of mucosal integrity. When the mucosal barrier is compromised, the tissue becomes more permeable to acid and pepsin damage. This may explain why some people develop increasingly severe LPR symptoms even when the quantity of reflux episodes remains relatively stable.

The PPI Paradox: How Reflux Treatment Can Worsen SIBO

This is one of the most important and frustrating aspects of the SIBO-reflux relationship, and one that I think is seriously under-discussed in mainstream reflux management.

PPIs work by dramatically reducing stomach acid production. For classic GERD with confirmed acid exposure, that can be appropriate short-term. But stomach acid isn’t just there to cause reflux — it’s a critical first line of defence against bacterial colonisation. When you suppress it chronically, you remove a key barrier that normally prevents bacteria from migrating into the small intestine.

A meta-analysis of 19 studies involving 7,055 participants found that PPI use was associated with a statistically significant increase in SIBO risk, with a pooled odds ratio of 1.71 [Lo & Luo, Alimentary Pharmacology & Therapeutics, 2017]. A separate large study of 1,815 individuals confirmed that PPIs are associated with a significant decrease in gut microbial diversity and changes in 20% of bacterial taxa [Imhann et al., Gut, 2016].

The cycle this creates is genuinely problematic:

1. You develop reflux symptoms
2. You’re prescribed PPIs
3. PPIs reduce stomach acid, removing the antibacterial barrier
4. SIBO develops or worsens
5. SIBO increases gas pressure and belching, triggering more reflux
6. Symptoms worsen or stop responding to medication
7. The dose is often increased — perpetuating the cycle

This is exactly the scenario I’ve seen discussed extensively in reflux communities, and it aligns with why so many people find that their acid reflux medication stops working over time. It’s not just tolerance — for some patients, the medication itself may be contributing to the bacterial problem driving their symptoms.

It’s worth noting that the 2025 Journal of Inflammation Research study found that short-term, low-dose acid-suppressive therapy (averaging 9–10 days) did not significantly affect SIBO development — so the concern is primarily with chronic, long-term PPI use rather than short courses.

SIBO and LPR: Why Throat Symptoms Are Often the Strongest Signal

In my research and reading on this topic, one finding stands out above the others: LPR patients appear to be disproportionately affected by SIBO, and treating SIBO specifically seems to improve LPR symptoms more than it improves classic heartburn symptoms.

The 2025 study by Chidambaram et al. — published in Diseases of the Esophagus and conducted across Imperial College London, Oxford, and RefluxUK — is the most important piece of evidence here. This was a retrospective cohort study of patients with SIBO or IMO presenting at a high-volume tertiary reflux clinic. After antibiotic treatment for SIBO, both GERD and LPR symptom scores improved significantly. The RSI (Reflux Symptom Index, which measures LPR-specific symptoms) decreased by a mean of 8.57 points — a clinically meaningful reduction. Most striking of all: 95% of patients were able to reduce or completely stop their PPI use after SIBO treatment, and 18 of 21 patients stopped PPIs entirely. Every single patient avoided the surgical interventions they had previously been heading towards [Chidambaram et al., Diseases of the Esophagus, 2025].

This is significant because it suggests that for a meaningful subset of people diagnosed with reflux — particularly those with LPR symptoms — the underlying problem isn’t inadequate acid suppression. It’s dysbiosis. The authors themselves concluded that diagnosis and treatment of SIBO in atypical reflux patients may prevent unnecessary surgical and pharmacological treatments.

The link to LPR symptoms specifically makes mechanistic sense. The belching-aerosol pathway I described earlier delivers pepsin and bile directly to the throat and larynx — tissues that are far more sensitive to irritation than the esophagus. And because SIBO is producing gas rather than acid, a normal pH test can completely miss it. Pepsin can remain active and damaging in tissues even in a non-acidic environment. This is one reason why LPR is so resistant to the standard treatment approach of acid suppression alone. You can read more about this in our article on silent reflux and bad breath, which also covers the SIBO connection in that specific symptom context.

SIBO Symptoms That Overlap With Reflux

Part of what makes SIBO so easy to miss in reflux patients is that many SIBO symptoms are routinely attributed to GERD or LPR. Knowing the overlap can help you recognise when the gut picture might be more complicated.

SIBO-specific symptoms worth looking out for include: bloating that worsens after eating carbohydrates (bread, pasta, fruit), excessive belching or flatulence, upper abdominal discomfort or distension, and a feeling of fullness that lingers longer than it should. Some people with methane-dominant SIBO experience constipation, while those with hydrogen-dominant SIBO may lean more toward looser stools or alternating bowel patterns.

The reflux overlap symptoms — heartburn, regurgitation, throat clearing, cough, globus, post-nasal drip — can all be driven by SIBO through the mechanisms I’ve outlined above. If you have a combination of both sets of symptoms and haven’t seen adequate relief from PPIs or H2 blockers, the case for investigating SIBO becomes considerably stronger.

How Is SIBO Diagnosed?

The standard diagnostic tool is a hydrogen-methane breath test. You consume a sugar solution — usually lactulose or glucose — and then breathe into collection bags at intervals over 90 to 180 minutes. In a healthy gut, lactulose travels through the small intestine without significant fermentation and reaches the colon before producing gases. In SIBO, bacteria in the small intestine ferment the sugar early, causing an earlier-than-expected rise in exhaled hydrogen or methane.

A ≥20 ppm rise in breath hydrogen within 90 minutes of ingestion is typically diagnostic of SIBO. Elevated methane levels indicate intestinal methanogen overgrowth (IMO), which is associated with constipation and the methane-dominant pattern more closely linked to GERD in the recent research.

The test is non-invasive, relatively inexpensive, and can be done at home. If you’re pursuing testing, avoid antibiotics and PPIs for 2–4 weeks beforehand to reduce false negatives — a practical consideration worth discussing with your doctor. I’d also recommend combining breath testing with a comprehensive stool analysis if you want a fuller picture of your gut health.

Treatment Approaches: Addressing Both SIBO and Reflux

If you test positive for SIBO, treatment typically targets the bacterial overgrowth directly, with the expectation that reflux symptoms often improve downstream as a result.

Antibiotic Options

Rifaximin is the most commonly used antibiotic for hydrogen-dominant SIBO. It’s a gut-specific antibiotic with minimal systemic absorption, making it generally well-tolerated. For methane-dominant SIBO (IMO), a combination of rifaximin and neomycin is often used, as methane-producing organisms (archaea) require a different antimicrobial approach. The Chidambaram et al. 2025 study used this approach in their cohort with the remarkable results noted above.

Herbal Antimicrobials

For milder cases or as an alternative to antibiotics, herbal protocols — including berberine, oregano oil, and allicin — are used in functional medicine settings. These have some evidence behind them and are worth discussing with a practitioner, particularly if you want to avoid antibiotics or have had recurrent SIBO. Berberine in particular is of interest for both its antimicrobial and prokinetic properties.

Prokinetics

Treating the bacterial overgrowth without addressing the motility issues that caused it in the first place is a common reason for SIBO recurrence. Prokinetics — substances that help the gut’s migrating motor complex (MMC) clear bacteria between meals — are often used as part of a maintenance or prevention strategy. Artichoke leaf extract and ginger are two natural prokinetics that are relatively accessible.

Dietary Approaches

A low-FODMAP diet reduces the fermentable carbohydrates that bacteria feed on, which can reduce gas production and symptom burden during treatment. An elemental diet — in which nutrients are provided in pre-digested form that leaves little for bacteria to ferment — is a more intensive option sometimes used for refractory SIBO. After treatment, gradual reintroduction of foods is important to avoid permanently restricting your diet and harming microbiome diversity.

Reducing PPI Dependence Where Appropriate

If your reflux has been primarily driven by SIBO rather than structural acid overproduction, successfully treating SIBO may allow you to reduce or eventually discontinue PPIs — which in turn reduces the ongoing risk of SIBO recurrence. This should be done gradually and under medical supervision, ideally with alginate-based products (like Gaviscon Advance) used as a bridging tool during the taper. Never stop PPIs abruptly due to the risk of rebound acid hypersecretion.

The Two-Group Pattern: Where You Might Fit

In clinical practice, reflux patients with SIBO tend to fall into two broad patterns, and understanding which one fits your situation matters for how treatment is approached.

The first group has genuine structural reflux — usually involving a hiatus hernia or significant LES failure — who have been on long-term PPIs. The PPIs have helped control acid but have simultaneously allowed SIBO to develop. In this group, both problems are real and need addressing. PPI reduction may ultimately require anti-reflux surgery or other structural interventions if SIBO treatment alone doesn’t fully resolve symptoms.

The second group was originally misdiagnosed with GERD when the primary driver was actually SIBO all along. These patients often have LPR-type symptoms, poor response to PPIs from the start, and significant bloating and belching. For this group, treating SIBO may resolve the reflux symptoms entirely — as seen in the majority of Chidambaram et al.’s cohort. A consultation with a reflux specialist who is familiar with the SIBO-reflux connection is invaluable in working out which category applies to you.

Putting It All Together

What the research is telling us, increasingly clearly, is that reflux is not always — or even primarily — a story about too much acid. For a significant number of people, particularly those with LPR or symptoms that haven’t responded to standard treatment, bacterial overgrowth in the small intestine is a central part of the problem. SIBO creates gas, that gas drives pressure, that pressure forces reflux — and meanwhile, the PPIs prescribed to manage the reflux are quietly making the bacterial situation worse.

The 2025 clinical data showing that treating SIBO allowed 95% of reflux patients to stop taking PPIs is genuinely remarkable. It suggests we’re in an early phase of recognising just how important gut dysbiosis is in the reflux picture — and that the standard treatment approach misses it almost entirely.

If you suspect SIBO is a factor for you, the path forward starts with testing, not guessing. A hydrogen-methane breath test is accessible, non-invasive, and far more informative than continuing to increase medication that isn’t resolving your underlying issue.

For the dietary side of the equation, the Wipeout Diet Plan was built with exactly this kind of complexity in mind — a framework that addresses reflux triggers at the source, focusing on the foods and patterns that reduce both acid exposure and the fermentation burden that feeds bacterial overgrowth. If you’ve been managing symptoms reactively and want a structured approach that goes deeper than avoiding spicy food, it’s worth exploring what a properly designed reflux diet can actually do.

Frequently Asked Questions

Can SIBO cause acid reflux?

Yes. SIBO causes bacteria in the small intestine to ferment food and produce gas, which creates upward pressure on the lower esophageal sphincter (LES). This pressure triggers the sphincter to relax at the wrong times, allowing stomach contents to reflux into the esophagus. Multiple studies have confirmed a significant statistical association between SIBO and GERD, with GERD identified as an independent risk factor for SIBO.

How do I know if SIBO is causing my reflux?

Signs that SIBO may be contributing include: reflux symptoms that haven’t responded well to PPIs, significant bloating (especially after carbohydrates), excessive belching, and symptoms that match LPR (throat clearing, cough, globus) rather than classic heartburn. A hydrogen-methane breath test is the standard diagnostic tool and can be arranged through your GP or privately.

Can PPIs cause SIBO?

Long-term PPI use is associated with a moderately increased risk of SIBO. PPIs reduce stomach acid, which is one of the body’s key defences against bacterial colonisation of the small intestine. A meta-analysis of 19 studies found a pooled odds ratio of 1.71 for SIBO risk in PPI users. Short-term PPI use does not appear to carry the same risk.

Does treating SIBO improve acid reflux?

In many patients, yes — particularly those with LPR symptoms. A 2025 clinical study found that treating SIBO with antibiotics led to significant improvements in both GERD and LPR symptom scores, with 95% of patients able to reduce or stop PPIs entirely. The effect is strongest in patients where SIBO (rather than structural issues like a hiatus hernia) is the primary driver of symptoms.

What is the connection between SIBO and LPR (silent reflux)?

SIBO appears to have a particularly strong association with LPR symptoms. The belching associated with SIBO releases an aerosol of gastric contents — including pepsin and bile — that reaches the throat and larynx, causing irritation that is not acid-dependent and therefore doesn’t respond to acid suppression. Research shows SIBO patients have significantly greater LPR symptom burden and impaired mucosal integrity in the proximal esophagus compared to those without SIBO.

What type of SIBO is most associated with acid reflux?

Methane-dominant SIBO (technically classified as intestinal methanogen overgrowth or IMO) has the strongest association with GERD in recent research. Methane-producing organisms slow gut motility and are associated with constipation, which increases the frequency of transient LES relaxations and therefore reflux episodes.

Can I test for SIBO at home?

Yes. Home breath test kits for SIBO are widely available and use the same hydrogen-methane methodology as clinical tests. You breathe into collection bags at intervals after consuming a lactulose solution. However, results should be interpreted alongside your symptom picture, and treatment decisions are best made with a knowledgeable practitioner involved.

Related Articles

• The Complete Guide to LPR (Silent Reflux)
• The Ultimate Guide to Acid Reflux and GERD
• Why Your Acid Reflux Medication May Not Be Working
• Silent Reflux and Bad Breath: The SIBO Connection
• Silent Reflux and Post-Nasal Drip: What’s Really Going On
• Understanding the Lower Esophageal Sphincter and LPR

Research Sources

GERD was significantly more prevalent in SIBO-positive patients than SIBO-negative patients, with methane-producing SIBO showing the strongest association, and GERD identified as an independent risk factor for SIBO via logistic regression [Wang et al., Journal of Inflammation Research, 2025]. Treating SIBO with antibiotics in reflux patients led to significant improvements in both GERD and LPR symptom scores, with 95% of patients able to reduce or stop PPIs and all patients avoiding surgical intervention [Chidambaram et al., Diseases of the Esophagus, 2025].

SIBO is associated with greater LPR symptom severity — particularly throat clearing, cough, and globus — and with impaired mucosal integrity in the proximal esophagus [Haworth et al., Gastrointestinal Tract, 2023]. Among patients referred for anti-reflux surgery, 60.6% had intestinal dysbiosis — with SIBO and IMO both common — and dysbiotic patients were more likely to have symptoms directly tied to reflux events [Haworth et al., Surgical Endoscopy, 2021].

A meta-analysis of 19 studies (7,055 participants) found that PPI use was associated with a statistically significant increase in SIBO risk, with a pooled odds ratio of 1.71 [Lo & Luo, Alimentary Pharmacology & Therapeutics, 2017]. PPI use is associated with a significant decrease in gut microbial diversity and changes to 20% of bacterial taxa in a population-based analysis of 1,815 individuals [Imhann et al., Gut, 2016].